Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

Journal of Pathology

Volumn 185, Issue 4, 1998, Pages 345-351

  Simon, Ronald ^a   Bürger, Horst ^a   Brinkschmidt, Christian ^a   Böcker, Werner ^a   Hertle, Lothar ^b   Terpe, Hans Joachim ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bladder neoplasms genetics; Bladder neoplasms pathology; Chromosome aberrations; Neoplasm staging; Nucleic acid hybridization; Oncogenes

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER STAGING; CHROMOSOME 17; CHROMOSOME 1Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEIC ACID HYBRIDIZATION; ONCOGENE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; URINARY BLADDER NEOPLASMS;

EID: 2642670285     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199808)185:4<345::AID-PATH109>3.0.CO;2-0     Document Type: Article

References (44)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Inr J Cancer 1993; 54: 594-606.
2. Murphy MW, Beckwith JB, Farrow GM. Tumors of the Kidney, Bladder and Related Urinary Structures. Washington, DC: Armed Forces Institute of Pathology, 1994; 193-248.
3. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800-803.
4. Cordon Cardo C, Dalbagni G, Sarkis AS, Reuter VE. Genetic alterations associated with bladder cancer. Important Adv Oncol 1994: 71-83.
5. Kallioniemi AH, Kallioniemi OP, Citro G, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995; 12: 213-219.
6. Sauter G, Carroll P, Moch H, et al. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 1995; 146: 1131-1139.
7. Reznikoff CA, Belair CD, Yaeger TR, et al. A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 1996: 571-584.
8. Richter J, Jiang F, Goeroeg JP, et al. Marked genetic differences between stage pTa and pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997; 57: 2860-2864.
9. Kallioniemi AH, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecualr cytogenetic analysis of solid tumors. Science 1992;258: 818-821.
10. Presti JC Jr, Moch H, Reuter VE, Cordon Cardo C, Waldman FM. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. J Urol 1996; 156: 281-285.
11. Visakorpi T, Kallioniemi AH, Syvanen AC, et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995; 55: 342-347.
12. Mostofi FK, Sobin LH, Torloni H. Histological Typing of Urinary Bladder Tumors. International Classification of Tumors. No. 10. Geneva: World Health Organization, 1973.
13. TNM Classification of Malignant Tumours. 4th edn. Berlin: Springer-Verlag, 1992.
14. American Joint Committee on Cancer (AJCC). Manual for Staging of Cancer. 3rd edn. Philadelphia: JP Lippincott, 1988.
15. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993; 90: 590-610.
16. Brinkschmidt C, Christiansen H, Terpe HJ, et al. Comparative genomic hybridization (CGH) analysis of neuroblaslomas - an important methodological approach in paediatric tumour pathology. J Pathol 1997; 181: 394-400.
17. Sauter G, Moch H, Gasser TC, Mihatsch MJ, Waldman FM. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 1995; 21: 40-46.
18. Ilyas M, Tomlinson IPM. Genetic pathways in colorectal cancer. Hisiopathology 1996: 389-399.
19. Sauter G, Deng G, Moch H, et al. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol 1994; 144: 756-766.
20. Cordon Cardo C, Reuter VE. Alterations of tumor suppressor genes in bladder cancer. Semin Diagn Pathol 1997; 14: 123-132.
21. Voorter C, Joos S, Bringuier PP, et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995; 146: 1341-1354.
22. Sandberg AA, Berger CS. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 1994; 151: 545-560.
23. Sutrave P, Hughes SH. The ski oncogene. Oncogene 1991; 6: 353-356.
24. Greco A, Villa R, Pierotti MA. Genomic organization of the human NTRK1 gene. Oncogene 1996; 13: 2463-2466.
25. O'Connell P, Lathrop GM, Nakamura Y, et al. Twenty-eight loci form a continuous linkage map of markers for human chromosome 1. Genomics 1989; 4: 12-20.
26. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996; 7: 565-577.
27. Walsh MD, Hohn BG, Thong W, et al. Mucin expression by transitional cell carcinomas of the bladder. Br J Urol 1994; 73: 256-262.
28. Bishop DT, Hall NR. The genetics of colorectal cancer. Eur J Cancer 1994; 30A: 1946-1956.
29. Zervos AS, Gyuris J, Brent R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites [published erratum appears in Cell 1994; 79(2): following 388]. Cell 1993; 72: 223-232.
30. Kallioniemi OP, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996; 68: 225-255.
31. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 1994; 54: 531-538.
32. Voorter CE, Ummelen MI, Ramaekers FS, Hopman AH. Loss of chromosome 11 and 11 p/q imbalances in bladder cancer detected by fluorescence in situ hybridization. Int J Cancer 1996; 65: 301-307.
33. Shaw ME, Knowles MA. Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer 1995; 13: 1-8.
34. Gibas Z, Prout GR Jr, Connolly JG, Pontes JE, Sandberg AA. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 1984; 44: 1257-1264.
35. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 1995; 64: 99-103.
36. Habuchi T, Devlin J, Elder PA, Knowles MA. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 1995; 11: 1671-1674.
37. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mal Genet 1995; 4: 1569-1577.
38. Okajima E, Fukuda T, Okita S, Tsutsumi M, Hirao Y, Konishi Y. Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers. Cancer Lett 1996; 103: 227-231.
39. Murphy DS, McHardy P, Coutts J, et al. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int J Cancer 1995; 64: 18-26.
40. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993; 62: 89-124.
41. Bringuier PP, Tamimi Y, Schuuring E, Schalken J. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 1996; 12: 1747-1753.
42. Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. Loss of hyterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. J Urol 1996; 155: 1444-1447.
43. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158: 62-67.
44. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologie grading? [published erratum appears in Cancer 1988; 61(7): 1385]. Cancer 1987; 60: 2766-2774.